0000000000160613

AUTHOR

E. Muscholl

showing 23 related works from this author

Vergleichende Untersuchung der Blutdruckwirkung, Aufnahme und Speicherung von Dihydroxyephedrin (?-Methyladrenalin) und Dihydroxypseudoephedrin

1966

PharmacologyChemistryPharmacology toxicologyGeneral MedicineMolecular biologyNaunyn-Schmiedebergs Archiv f�r Pharmakologie und Experimentelle Pathologie
researchProduct

Die Wirkung sympathomimetischer Amine auf den sympathischen Reizerfolg am perfundierten A. mesenterica-Pr�parat der Ratte

1967

Pharmacologybusiness.industryPharmacology toxicologyMedicineGeneral MedicinePharmacologybusinessNaunyn-Schmiedebergs Archiv f�r Pharmakologie und Experimentelle Pathologie
researchProduct

�ber den nachweis und die bedeutung von ?-methylnoradrenalin im harn von hypertonikern bei verabreichung von ?-methyldopa

1968

An 13 Hypertonikern wurde die Harnausscheidung von α-Methyldopa, α-Methyldopamin und Katecholammen wahrend einer Dauerbehandlung oder nach einer Einzeldosis von α-Methyldopa untersucht. Die im Harn enthaltenen Substanzen werden durch Ionenaustausch- und Papierchromatographie voneinander getrennt und fluorometrisch oder biologisch bestimmt. — Von alien Patienten wurde auser freiem und konjugiertem α-Methyldopa und α-Methyldopamin auch α-Methylnoradrenalin ausgeschieden. Gleichzeitig nahm die Ausscheidung von Noradrenalin gegenuber der Vor-und Nachperiode bei fast allen Patienten ab. Es kann ausgeschlossen werden, das die bei der Behandlung durch die Nieren ausgeschiedenen Mengen von α-Methyl…

PharmacologyGynecologymedicine.medical_specialtyChemistryPharmacology toxicologymedicinePharmacology (medical)General MedicinePharmacologia Clinica
researchProduct

Inhibition by parasympathetic nerve stimulation of the release of the adrenergic transmitter

1970

Isolated rabbit atria were perfused with Tyrode solution containing (+)-amphetamine. Electrical stimulation of the right postganglionic sympathetic fibres caused an output of noradrenaline which was significantly decreased by simultaneous stimulation of the vagus nerves.

Atropinemedicine.medical_specialtyDextroamphetamineSympathetic Nervous SystemStellate GanglionPharmacology toxicologyAdrenergicStimulationSimultaneous stimulationNorepinephrineInternal medicinemedicineAnimalsHeart AtriaAmphetaminePharmacologyChemistryHeartVagus NerveGeneral MedicineParasympathetic nerveElectric StimulationPerfusionEndocrinologyTyrode solutionAutonomic Fibers PostganglionicRabbitsmedicine.drugNaunyn-Schmiedebergs Archiv f�r Pharmakologie
researchProduct

PRESYNAPTIC MUSCARINIC CONTROL OF NORADRENALINE RELEASE

1980

ChemistryMuscarinic acetylcholine receptorMuscarinic acetylcholine receptor M4Muscarinic acetylcholine receptor M1Pharmacology
researchProduct

Über einen durch Nicotinreceptoren vermittelten Block an der postganglionären sympathischen Nervenfaser

1969

PharmacologyGynecologymedicine.medical_specialtyChemistryPharmacology toxicologymedicineGeneral MedicineNaunyn-Schmiedebergs Archiv für Pharmakologie
researchProduct

A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation

1969

1. The noradrenaline output from isolated rabbit hearts perfused with Tyrode solution was estimated fluorimetrically. The postganglionic sympathetic nerves of the heart were stimulated (10 shocks/sec; 1 msec) for three 1 min periods with intervals of 10 min. 2. The noradrenaline output evoked by 3 consecutive stimulation periods decreased exponentially. 3. Acetylcholine (10−9–10−6 g/ml) administered continuously one min before to one min after the second stimulation caused a dose-dependent reduction of the noradrenaline output evoked by the second stimulation to as low as 19% of the normal value. Acetylcholine in the concentrations applied did not cause a noradrenaline output by itself. 4. …

AtropineMalemedicine.medical_specialtySympathetic Nervous SystemTyramineStimulationHexamethonium CompoundsIn Vitro TechniquesPiperazinesNorepinephrinechemistry.chemical_compoundInternal medicineMuscarinic acetylcholine receptormedicineAnimalsMethacholine CompoundsFluorometryReceptors CholinergicPharmacologyHeartAdrenergic nervous systemGeneral MedicineCoronary VesselsAcetylcholineElectric StimulationReceptors AdrenergicPerfusionQuaternary Ammonium CompoundsAtropineEndocrinologyParasympathomimeticschemistryDepression ChemicalAutonomic Fibers PostganglionicCholinergicFemaleHexamethoniumMethacholineRabbitsAcetylcholinemedicine.drugNaunyn-Schmiedebergs Archiv f�r Pharmakologie
researchProduct

Die Ausscheidung von ?-Methylnoradrenalin im Harn von Hypertonikern w�hrend einer Behandlung mit ?-Methyldopa

1967

PharmacologyChemistryPharmacology toxicologyGeneral MedicinePharmacologyNaunyn-Schmiedebergs Archiv f�r Pharmakologie und Experimentelle Pathologie
researchProduct

Die Ausscheidung von Katecholaminen und Aminmetaboliten von α-Methyldopa in den Harn zu verschiedenen Zeitpunkten nach der letzten verabreichten Dosis

1969

PharmacologyChemistryPharmacology toxicologyGeneral MedicinePharmacologyNaunyn-Schmiedebergs Archiv für Pharmakologie
researchProduct

Die Wirkung von Ouabain auf die Elimination von Noradrenalin aus der Perfusionsfl�ssigkeit des isolierten Kaninchenherzens

1966

Isolated rabbit hearts were perfused with Tyrode solution containing 10 ng/ml (-)-noradrenaline for 20 min. The uptake by the heart of noradrenaline was calculated by estimating the percentage of amine removed from the perfusion fluid during a single passage through the heart. Previous experiments have shown that the amount of noradrenaline removed from the perfusion fluid corresponds well to the amount retained by the heart. In control experiments, the mean removal (elimination) of noradrenaline was 50±1.7% of the amount infused as measured biologically and 46±2.2% as measured fluorimetrically. Ouabain was added to the perfusion fluid at concentrations ranging from 2.74·10−7 to 2.0·10−6 mo…

PharmacologyInotropemedicine.medical_specialtyPotassiumNoradrenaline transportSodiumchemistry.chemical_elementGeneral Medicinemedicine.diseaseOuabainCell membraneEndocrinologymedicine.anatomical_structurechemistryInternal medicineMolemedicineAtrioventricular blockmedicine.drugNaunyn-Schmiedebergs Archiv f�r Pharmakologie und Experimentelle Pathologie
researchProduct

Elektrophysiologische Untersuchung der einzelnen Faseranteile des isolierten Rattenzwerchfelles

1957

PhysiologyChemistryPhysiology (medical)Clinical BiochemistryHuman physiologyReceptorMolecular medicineMolecular biologyPfl�gers Archiv f�r die Gesamte Physiologie des Menschen und der Tiere
researchProduct

Cholinergic-Adrenergic Interactions at the Presynaptic Level as Studied in the Heart

1982

ChemistryAdrenergicCholinergicNeuroscience
researchProduct

Funktionelle Bedeutung der Freisetzung von Dihydroxyephedrin und Dihydroxypseudoephedrin als ?falschen? sympathischen �bertr�gerstoffen am Herzen

1967

The experiments were carried out in order to investigate the functional significance of substitution of noradrenaline by amines known to exert actions weaker than those of the natural transmitter. On the isolated rabbit heart the potency relative to noradrenaline of (±)-dihydroxyephedrine to increase the rate was 1/4 and the potency to augment the contractile amplitude was 1/6. The corresponding values for (±)-dihydroxypseudoephedrine were 1/67 and 1/140, respectively.

Pharmacologymedicine.medical_specialtyEndocrinologyStereochemistryChemistryRabbit heartInternal medicinePharmacology toxicologymedicinePotencyFunctional significanceGeneral MedicineNaunyn-Schmiedebergs Archiv f�r Pharmakologie und Experimentelle Pathologie
researchProduct

Wirkungen von threo-1-(3,4-Dihydroxyphenyl)-1-hydroxy-2-aminopropan, dem Diastereomeren von Corbadrin

1967

PharmacologyStereochemistryChemistryPharmacology toxicologyGeneral MedicineNaunyn-Schmiedebergs Archiv f�r Pharmakologie und Experimentelle Pathologie
researchProduct

The role of vagus activity in the presynaptic control of noradrenaline release from rabbit atria.

1990

Abstract On various heart preparations with the autonomic innervation left intact, vagus nerve stimulation (VNS) has been found to reduce the amount of noradrenaline (NA) that is released in response to sympathetic nerve stimulation (SNS). The following experiments were carried out on an innervated rabbit perfused atria preparation in which the overflow of NA and acetylcholine (ACh) could be determined simultaneously. VNS impulses applied at a fixed time interval before the corresponding SNS impulses reduced NA overflow when the interval was 3–10 ms (early peak) or 200–283 ms (late peak of inhibition). VNS applied 30–167 ms before SNS had no significant effect (“ineffectual period”). Both i…

medicine.medical_specialtyMuscarineMuscarinic acetylcholine receptor M2Cell BiologyMuscarinic acetylcholine receptor M1PirenzepineVagus nerveCellular and Molecular Neurosciencechemistry.chemical_compoundEndocrinologychemistryInternal medicineMuscarinic acetylcholine receptormedicineAutoreceptorAcetylcholinemedicine.drugNeurochemistry international
researchProduct

RELEASE OF CATECHOLAMINES FROM THE HEART

1966

Publisher Summary This chapter discusses the release of catecholamines from the heart. The isolated heart of the rabbit with the sympathetic nervous supply from the right stellate ganglion intact was set up according to Hukovio and Muscholl. The ganglion was stimulated for 30 s at supramaximal voltage with rectangular impulses of 3–5 ms duration a frequency of 10 shocks/s. Each stimulation period was followed by a resting period of 30 s. In the rabbit, four doses of 50 mg/kg l-α-methyldopa decreased the noradrenaline concentration in auricles, right, and left ventricles by 38–60%. An equimolar amount of α-methyl noradrenaline was detected in the tissues. Reserpine and guanethidine in doses,…

medicine.medical_specialtyMonoamine oxidaseChemistryStimulationIsolated heartLeft VentriclesReserpineGanglionEndocrinologymedicine.anatomical_structureStellate ganglionInternal medicinemedicineGuanethidinemedicine.drug
researchProduct

Pharmakologische Grundlagen der Receptorenblockade

1972

Wenn ich im folgenden uber pharmakologische Grundlagen der adrenergen Receptorenblockade berichte, so mochte ich zunachst einige physiologische Wirkungen besprechen, die durch adrenerge Receptoren vermittelt warden. Daran anschliesend werde ich den Einflus der Receptorenhemmstoffe auf Organfunktionen besprechen.

researchProduct

Die Hemmung der Noradrenalin-Abgabe durch Acetylcholin am sympathisch gereizten, isolierten Kaninchenherzen / The Inhibitory Effect of Acetylcholine …

1969

Nicotinartig wirkende Substanzen setzen aus chromaffinen Zellen und aus sympathischen Nervenendigungen Noradrenalin (NA) frei. Am isolierten Saugetierherzen wird diese NA-Freisetzung aber gehemmt, wenn gleichzeitig Muscarinreceptoren z. B. durch Acetylcholin (ACh) oder Methacholin erregt werden (Lindmau Loffelholz u. Muscholl

medicine.medical_specialtyEndocrinologyChemistryInternal medicinemedicineInhibitory effectAcetylcholinemedicine.drug
researchProduct

�ber die Bedeutung der Bildung von Metaboliten f�r die blutdrucksenkende Wirkung von ?-Methyldopa

1967

PharmacologyChemistryPharmacology toxicologyGeneral MedicinePharmacologyNaunyn-Schmiedebergs Archiv f�r Pharmakologie und Experimentelle Pathologie
researchProduct

THE MECHANISM OF NEURONAL RELEASE OF ADRENERGIC TRANSMITTERS BY LOW SODIUM AND HYPO-OSMOTIC SHOCK

1979

Osmotic shockChemistryMechanism (biology)BiophysicsAdrenergicLow sodium
researchProduct

Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves

2006

Chemistrymedicine.medical_treatmentMuscarinic acetylcholine receptormedicineAcetylcholine metabolismPharmacologyHeteroreceptorReceptorMyenteric plexusAcetylcholineVagus nerve stimulationmedicine.drugPeripheral
researchProduct

Die Hemmung der Noradrenalin-Abgabe durch Acetylcholin am sympathisch gereizten, isolierten Kaninchenherzen

1969

PharmacologyChemistryPharmacology toxicologyGeneral MedicinePharmacologyNaunyn-Schmiedebergs Archiv f�r Pharmakologie und Experimentelle Pathologie
researchProduct

DRUGS INTERFERING WITH THE STORAGE AND RELEASE OF ADRENERGIC TRANSMITTERS

1965

ChemistryAdrenergicPharmacology
researchProduct